Novartis, Drop the Case!

For seven years the drug company Novartis refused to back down on its legal case to stop the production of affordable generic medicines in India.  MSF with others ardently opposed this attack on life-saving medicines that save millions of lives in developing countries.  In April 2013, India’s Supreme Court finally ruled against Novartis, shoring up public health protections enshrined in India’s patent law.

1. April 2013.

Indian Supreme Court rejects Novartis' Appeal

The Indian Supreme Court's landmark decision to uphold India's Patents Act in the face of the seven-year challenge by Swiss pharmaceutical company Novartis is a major victory for patients' access to affordable medicines in developing countries. 


India 2012 © MSF

About the Campaign

India 2007 © Sheila Shettle/MSF

The "Drop the Case" campaign called for drug giant Novartis to drop its legal case aimed at gutting India’s patent law of important public health safeguards.  

» Read more

Results of 2012 Campaign

India 2011 © Guddu

Thank you to the more than 20,000 people who sent messages calling for Novartis to put the lives of people before profits. 

» Visit the Campaign site

Voice of the Campaign


Leena Menghaney, who works for the Access Campaign in New Delhi, describes one of the biggest challenges facing activists campaigning about the Novartis trial. 

» Read more

Results of 2006 Campaign

Switzerland 2007 © MSF

Nearly half a million people, including Archbishop Desmond Tutu, author John Le Carré and former Swiss President Ruth Dreifuss, signed our petition calling on Novartis to ‘Drop the Case’ in 2006. 


Next steps

The Supreme Court of India issued a verdict on 1 April 2013 upholding the Indian Patent Law and rejecting Novartis' appeal. 


↑ To top